Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India ( Depositories and Participants)Regulations, 2018 for quarter ended December 31,2025
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted to the exchanges a quarterly certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India), for the quarter ended December 31, 2025. The certificate confirms that all share certificates received from depository participants for dematerialisation during the quarter were duly processed, accepted or rejected, and the corresponding securities were listed on the stock exchanges. It also confirms that physical certificates received for demat were mutilated and cancelled after verification, and the depository names were substituted in the register of members as the registered owners within the prescribed timelines. This is a routine SEBI compliance filing required every quarter and contains no business or financial information.
No impact on shareholders or stock price — this is a standard procedural compliance filing confirming that dematerialisation activities were properly processed during the October–December 2025 quarter.